FDF products

Colistimethate sodium is a prodrug of colistin which is a mixture of polypeptide antibiotics active against gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Indication: Used in the treatment of patients with serious infections due to selected aerobic gram-negative pathogens with limited treatment options.

Application: Administered intrathecally, by intraventricular administration, or as intravenous infusion.

Colistimethate sodium is a prodrug of colistin, which is a mixture of polypeptide antibiotics active against gram-negative bacteria, including Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae, and especially Pseudomonas aeruginosa.

Indication: Used in the treatment of acute or chronic infections due to sensitive strains of gram-negative pathogens. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.

Application: Administered systemically as intramuscular injections and intravenous injections or infusions.

Daptomycin is a lipopeptide antibacterial agent active against gram-positive bacteria.

Indication: Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of gram-positive bacteria such as Staphylococcus aureus (including MRSA-methicillin-resistant Staphylococcus aureus), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae supsp. equisimilis and Enterococcus faecalis (vancomycin-susceptible isolates only).

Additionally used for bloodstream infections (bacteremia), including patients with right-sided infective endocarditis caused by Staphylococcus aureus.

Application: Administered as intravenous infusions or injections.

Daptomycin is a lipopeptide antibacterial agent active against gram-positive bacteria.

Indication: Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of gram-positive bacteria such as Staphylococcus aureus (including MRSA-methicillin-resistant Staphylococcus aureus), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae supsp. equisimilis and Enterococcus faecalis (vancomycin-susceptible isolates only).

Additionally used for bloodstream infections (bacteremia), including patients with right-sided infective endocarditis caused by Staphylococcus aureus.

Application: Administered as intravenous infusions or injections.

Polymyxin B is a mixture of the sulfates of polypeptide antibiotics active against almost all gram-negative bacteria except the Proteus group.

Indication: Used in the treatment of patients with acute urinary, meningeal or blood-stream infections due to susceptible strains such as Pseudomonas aeruginosa, Haemophilus influenzae, Escherichia coli, Aerobacter aerogenes or Klebsiella pneumoniae.

Application: Administered systemically as intravenous infusions, intramuscular or intrathecal injections, and locally as eye drops or subconjunctival injections.